FR2322593A1 - Nouveaux analogues de prostaglandines et medicament les contenant - Google Patents

Nouveaux analogues de prostaglandines et medicament les contenant

Info

Publication number
FR2322593A1
FR2322593A1 FR7626393A FR7626393A FR2322593A1 FR 2322593 A1 FR2322593 A1 FR 2322593A1 FR 7626393 A FR7626393 A FR 7626393A FR 7626393 A FR7626393 A FR 7626393A FR 2322593 A1 FR2322593 A1 FR 2322593A1
Authority
FR
France
Prior art keywords
products containing
medicinal products
prostaglandin analogues
new prostaglandin
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7626393A
Other languages
English (en)
Other versions
FR2322593B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of FR2322593A1 publication Critical patent/FR2322593A1/fr
Application granted granted Critical
Publication of FR2322593B1 publication Critical patent/FR2322593B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C07D307/935Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/15Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen containing halogen
    • C07C53/19Acids containing three or more carbon atoms
    • C07C53/21Acids containing three or more carbon atoms containing fluorine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5407Acyclic saturated phosphonium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7626393A 1975-09-02 1976-09-01 Nouveaux analogues de prostaglandines et medicament les contenant Granted FR2322593A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60941075A 1975-09-02 1975-09-02

Publications (2)

Publication Number Publication Date
FR2322593A1 true FR2322593A1 (fr) 1977-04-01
FR2322593B1 FR2322593B1 (fr) 1983-10-21

Family

ID=24440691

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7626393A Granted FR2322593A1 (fr) 1975-09-02 1976-09-01 Nouveaux analogues de prostaglandines et medicament les contenant

Country Status (9)

Country Link
US (6) US4138576A (fr)
JP (1) JPS5233651A (fr)
AU (1) AU502427B2 (fr)
BE (1) BE845780A (fr)
DE (1) DE2638827A1 (fr)
FR (1) FR2322593A1 (fr)
GB (1) GB1528074A (fr)
NL (1) NL7609538A (fr)
ZA (1) ZA764727B (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2373527A1 (fr) * 1976-12-08 1978-07-07 Hoffmann La Roche Nouvelles prostaglandines
FR2378009A2 (fr) * 1977-01-21 1978-08-18 Hoechst Ag Nouveaux analogues de prostaglandines, leur procede de preparation et leurs applications therapeutiques
EP0000207A1 (fr) * 1977-07-05 1979-01-10 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Dérivés prostaglandines, leur préparation et compositions pharmaceutiques et composés intermédiaires
EP0001255A1 (fr) * 1977-09-21 1979-04-04 Hoechst Aktiengesellschaft Dérivés fluorés de prostaglandines, procédé pour leur fabrication et leur utilisation comme médicament

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293704A (en) * 1975-09-25 1981-10-06 American Cyanamid Company Novel 2-substituted-3,4-epoxycyclopentan-1-ones, 2-substituted-3,4-epoxycyclopentan-1-ols, and various 2-substituted-cyclopentenones
US4187381A (en) * 1973-08-06 1980-02-05 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
US4312810A (en) * 1978-11-22 1982-01-26 The Upjohn Company 2,5-Inter-o-phenylene-3,4-dinor-5,9α-epoxy-9-deoxy-PGF1 compounds
US4306078A (en) * 1979-12-03 1981-12-15 Hoffmann-La Roche Inc. 16-Substituted prostaglandins
US6808933B1 (en) * 2000-10-19 2004-10-26 Agilent Technologies, Inc. Methods of enhancing confidence in assays for analytes
JP5147404B2 (ja) * 2005-01-27 2013-02-20 スキャンポ・アーゲー 中枢神経系障害の処置のための方法および組成物
TWI432201B (zh) * 2005-03-04 2014-04-01 Sucampo Ag 11-去氧基-***素化合物用於治療週邊血管疾病之用途
WO2016090461A1 (fr) * 2014-12-10 2016-06-16 Apotex Inc. Sels d'intermédiaires d'analogues de prostaglandines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3935261A (en) * 1970-01-23 1976-01-27 May & Baker Limited Cyclopentane derivatives
US3932479A (en) * 1973-04-27 1976-01-13 American Cyanamid Company Lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2373527A1 (fr) * 1976-12-08 1978-07-07 Hoffmann La Roche Nouvelles prostaglandines
FR2378009A2 (fr) * 1977-01-21 1978-08-18 Hoechst Ag Nouveaux analogues de prostaglandines, leur procede de preparation et leurs applications therapeutiques
EP0000207A1 (fr) * 1977-07-05 1979-01-10 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Dérivés prostaglandines, leur préparation et compositions pharmaceutiques et composés intermédiaires
EP0001255A1 (fr) * 1977-09-21 1979-04-04 Hoechst Aktiengesellschaft Dérivés fluorés de prostaglandines, procédé pour leur fabrication et leur utilisation comme médicament

Also Published As

Publication number Publication date
NL7609538A (nl) 1977-03-04
US4138577A (en) 1979-02-06
AU1662576A (en) 1978-02-09
ZA764727B (en) 1977-07-27
GB1528074A (en) 1978-10-11
FR2322593B1 (fr) 1983-10-21
JPS5233651A (en) 1977-03-14
US4138575A (en) 1979-02-06
DE2638827A1 (de) 1977-03-10
AU502427B2 (en) 1979-07-26
US4163110A (en) 1979-07-31
US4126754A (en) 1978-11-21
BE845780A (fr) 1977-03-02
US4138576A (en) 1979-02-06
US4138573A (en) 1979-02-06

Similar Documents

Publication Publication Date Title
FR2353290A1 (fr) Nouveaux analogues de prostaglandines, leur procede de preparation et medicament les contenant
BE871907A (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et medicament les contenant
FR2279406A1 (fr) Nouveaux derives de quinazoline et medicament les contenant
IT1041962B (it) Dispositivo per l inalazione di medicinali
FR2307525A1 (fr) Analogues acetyleniques de prostaglandines et medicaments qui en contiennent
FR2318637A1 (fr) Nouveaux acides morpholine-carboxyliques, leur synthese et medicament les contenant
BE804558A (fr) Nouveaux derives de 2-amino- ou 4-amino-quinazoline et medicaments les contenant
BE791345A (fr) Nouveaux benzofurannes substitues et medicament les contenant
FR2322593A1 (fr) Nouveaux analogues de prostaglandines et medicament les contenant
FR2453851B1 (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
FR2273554A1 (fr) Derives de prostaglandines et medicaments contenant ces substances
FR2321898A1 (fr) Medicament contenant un poly-(amino-acide)
FR2289204A1 (fr) Nouveaux peptides et medicament contenant ces substances
FR2326185A1 (fr) Nouveaux analogues des prostaglandines et leur preparation
FR2315268A1 (fr) Nouvelles lactones de prostaglandines, leur procede de preparation et medicament les contenant
LU81253A1 (fr) Derives de di-o-n-alkylglycerols et medicament immuno-stimulant les contenant
BE874993A (fr) Nouveaux analogues de prostaglandines et medicament les contenant
FR2307526A1 (fr) Oxo-11 prostaglandines et medicaments qui en contiennent
BE864644A (fr) Nouveaux derives de prostaglandines, leur procede de preparation et medicaments les contenant
FR2335228A1 (fr) Derives de la 5-fluoro-pyrimidine-4-one et medicament contenant ces substances
FR2310132A1 (fr) 14b-hydroxy-3-desoxycardenolides et analogues de ceux-ci, leur preparation et compositions pharmaceutiques les contenant
BE853155A (fr) Nouveaux derives de sucres amines et medicament les contenant
FR2281766A1 (fr) Oestratetraenes et medicament contenant ces substances
BE832725A (fr) Nouveaux composes meterocycliques et composition pharmaceutique les contenant
FR2314724A1 (fr) Medicament anticonvulsif contenant un diphenylsilane

Legal Events

Date Code Title Description
ST Notification of lapse